Live symbol workspace

HIMS market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $19.15

Trend Flat

Sentiment Neutral

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support

$18.19

Resistance

$20.11

Volume & Momentum

Volume

Weak

0.8x avg

Momentum

0%

Weak

Technical Context

Current price

$19.15

RSI context

50

Market Sentiment

50

Neutral

Stock Metrics

Daily Vol

0%

VIX Est

20

Weekly

0%

Asset Intelligence Dossier

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

30%

— 0.0 pts vs previous week

Avg confidence across 6 calls in the last 7 days

What sources say

No news-sourced AI calls in the last 30 days.

Insider Trading

Insider	Role	Date	Type	Value
Pendarvis Christiane	Former Director	Jul 22 '26	Proposed Sale	113278.0
Okupe Oluyemi	Chief Financial …	Jul 17 '26	Option Exercise	35887.0
Okupe Oluyemi	Chief Financial …	Jul 17 '26	Sale	229168.0
Okupe Oluyemi	Chief Financial …	Jul 06 '26	Option Exercise	35887.0
Okupe Oluyemi	Chief Financial …	Jul 06 '26	Sale	261351.0
Oluyemi Okupe	Officer	Jul 06 '26	Proposed Sale	1096799.0
Carroll Patrick Harrison	Chief Medical …	Jun 18 '26	Sale	830410.0
Okupe Oluyemi	Chief Financial …	Jun 22 '26	Option Exercise	31944.0
Okupe Oluyemi	Chief Financial …	Jun 22 '26	Sale	619217.0
Carroll Patrick Harrison	Officer	Jun 18 '26	Proposed Sale	830410.0

Source: FinViz — Data may be delayed

Technical Observations

Refreshing technical observations from FinViz...

HIMS News Intelligence (15 articles)

AI-curated news influencing HIMS price, sentiment, and trend

Explore All HIMS News with AI Analysis

Economy

3 months ago

US Premarket Movers: Hims & Hers, PPG Industries, QuidelOrtho

S&P 500 Index futures rise 0.1% as of 7:51 a.m. in New York as an upbeat forecast from TSMC lifts …

Impact on HIMS: Neutral market sentiment indicated

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence. High (94%)

View full analysis →

Bloomberg 94% confidence

Stocks

3 months, 1 week ago

Hims & Hers stock jumps as U.S. moves forward with plan to reassess popular peptides

Hims & Hers Health’s plan to enter the business of selling peptides is looking a lot more realistic.

Impact on HIMS: Neutral market sentiment indicated

FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence. High (94%)

View full analysis →

MarketWatch 94% confidence

Economy

4 months ago

Top 2 S&P 500 Stocks to Watch This Week After Hims & Hers Stock's Surprise Move

These companies are benefiting from a tidal wave of demand for new weight-loss drugs.

Impact on HIMS: The increased demand for weight-loss drugs could lead to a surge in …

The recent surge in demand for new weight-loss drugs is expected to benefit top S&P … High (70%)

View full analysis →

Yahoo Finance 70% confidence